Stomach dose-volume parameters and clinical factors predict acute toxicity in pancreatic cancer chemoradiotherapy

Stomach dose-volume parameters and clinical factors predict acute toxicity in pancreatic cancer chemoradiotherapy

Gastrointestinal (GI) toxicity impedes dose escalation and likelihood of cure in chemoradiotherapy (CRT) for hepatobiliary malignancies. The risk of toxicity can depend on clinical and radiotherapy (RT) dose-volume metrics. We aimed to identify predictive factors using data from two prospective phas...

Detaylı Bibliyografya
Asıl Yazarlar:	Holyoake, D, Partridge, M, Hurt, C, Mukherjee, S, Hawkins, M
Materyal Türü:	Conference item
Baskı/Yayın Bilgisi:	Elsevier 2017

Benzer Materyaller

Stomach dose-volume predicts acute gastrointestinal toxicity in chemoradiotherapy for locally advanced pancreatic cancer
Yazar:: Holyoake, DLP, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Dosimetric parameters predict toxicity in chemoradiotherapy with nelfinavir for pancreatic cancer
Yazar:: Holyoake, D, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data
Yazar:: Holyoake, D, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Systematic review and meta-analysis of small bowel dose–volume and acute toxicity in conventionally-fractionated rectal cancer radiotherapy
Yazar:: Holyoake, D, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Meta-analysis of toxicity and small-bowel radiotherapy dose-volume: “omnibus consequentia”
Yazar:: Holyoake, D, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Can protons reduce bone marrow toxicity in definitive chemoradiotherapy for oesophageal tumours?
Yazar:: Warren, S, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Correlation of 18F-fluorodeoxyglucose positron emission tomography parameters with patterns of disease progression in locally advanced pancreatic cancer after definitive chemoradiotherapy
Yazar:: Wilson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

EP-1721: Feature extraction from duodenal dose surface maps to predict toxicity in pancreatic chemoradiation
Yazar:: Witztum, A, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Pixel-based analysis of stomach dose-surface maps to improve toxicity predictions in gastrointestinal radiotherapy
Yazar:: Witztum, A, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Radiobiological determination of dose escalation and normal tissue toxicity in definitive chemoradiation therapy for esophageal cancer.
Yazar:: Warren, S, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Potential of Proton Therapy to Reduce Acute Hematologic Toxicity in Concurrent Chemoradiation Therapy for Esophageal Cancer
Yazar:: Warren, S, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Conformity analysis to demonstrate reproducibility of target volumes for Margin-Intense Stereotactic Radiotherapy for borderline-resectable pancreatic cancer.
Yazar:: Holyoake, D, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Investigating the toxicity and safety of radiotherapy for pancreatic cancer
Yazar:: Holyoake, D
Baskı/Yayın Bilgisi: (2018)

Modelling normal tissue toxicity in pancreatic chemoradiotherapy
Yazar:: Witztum, A
Baskı/Yayın Bilgisi: (2018)

SU-F-T-108: Texture analysis for toxicity prediction from dose surface maps.
Yazar:: Witztum, A, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: the phase 1/randomised phase 2 SCALOP-2 trial
Yazar:: Mukherjee, S, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Conformity analysis of target-volume definition for margin-directed boost in pancreatic cancer SBRT
Yazar:: Holyoake, D, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: A radiobiological investigation
Yazar:: Carrington, R, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Acute chemoradiotherapy toxicity in cervical cancer patients
Yazar:: Radojevic Marija Zivkovic, ve diğerleri
Baskı/Yayın Bilgisi: (2020-09-01)

The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: a radiobiological investigation
Yazar:: Warren, S, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Stomach and duodenum dose–volume constraints for locally advanced pancreatic cancer patients treated in 15 fractions in combination with chemotherapy
Yazar:: Sara Broggi, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

ARCII: Nelfinavir, a hypoxia-modifying agent, in combination with chemoradiotherapy (CRT) in locally-advanced pancreatic cancer (LAPC)–mechanism and clinical outcomes
Yazar:: Wilson, J, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

The impact of bone marrow irradiation dose on acute haematologic toxicity in cervical cancer patients treated with concurrent chemoradiotherapy
Yazar:: Min Chen, ve diğerleri
Baskı/Yayın Bilgisi: (2023-04-01)

Inflammatory Parameters as Available Prognostic Factors for Pancreatic Cancer after Chemoradiotherapy
Yazar:: Chang Min Cho
Baskı/Yayın Bilgisi: (2018-05-01)

A comparison of dose-volume constraints derived using peak and longitudinal definitions of late rectal toxicity.
Yazar:: Gulliford, S, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis
Yazar:: Kuniaki Katsui, ve diğerleri
Baskı/Yayın Bilgisi: (2019-11-01)

ACUTE AND LATE TOXICITY WITH CHEMORADIOTHERAPY FOR OROPHARYNGEAL CANCER DEPENDING ON THE FRACTIONATION OPTION
Yazar:: Parkhomenko L. B.
Baskı/Yayın Bilgisi: (2018-12-01)

Low skeletal muscle mass is predictive of dose-limiting toxicities in head and neck cancer patients undergoing low-dose weekly cisplatin chemoradiotherapy.
Yazar:: Jan-Niklas Becker, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

ANALYSIS OF HEMATOLOGIC, HEPATIC AND PANCREATIC TOXICITY DURING NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER
Yazar:: V. Yu. Skoropad, ve diğerleri
Baskı/Yayın Bilgisi: (2018-07-01)

Improper lung volume-dose parameters are risk factors for acute fatal radiation pneumonitis among esophageal cancer patients receiving chemoradiotherapy: a case-control study
Yazar:: Ruinuo Jia, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

SU-D-BRA-06: Duodenal interfraction motion with abdominal compression.
Yazar:: Witztum, A, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Radiation pneumonitis after definitive concurrent chemoradiotherapy with cisplatin/docetaxel for non‐small cell lung cancer: Analysis of dose‐volume parameters
Yazar:: Kuniaki Katsui, ve diğerleri
Baskı/Yayın Bilgisi: (2020-07-01)

Primary diffuse large b-cell lymphoma of the stomach presenting as acute pancreatitis
Yazar:: Sara Ghani, ve diğerleri
Baskı/Yayın Bilgisi: (2020-06-01)

Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients.
Yazar:: Sebastian Zschaeck, ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01)

Risk factor of pneumonitis on dose-volume relationship for chemoradiotherapy with durvalumab: Multi-institutional research in Japan
Yazar:: Yoshiko Oshiro, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

EP-1720: Impact of contouring variability on tumour control and normal tissue toxicity in liver SBRT
Yazar:: Robinson, M, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

The relationship between the radiation dose of pelvic-bone marrow and lymphocytic toxicity in concurrent chemoradiotherapy for cervical cancer
Yazar:: Bao-Zhong Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

ECTOPIC PANCREATIC TISSUE IN THE STOMACH: CASE REPORT
Yazar:: Dejan Lukic, ve diğerleri
Baskı/Yayın Bilgisi: (2017-04-01)

Postoperative chemoradiotherapy combined with epirubicin-based triplet chemotherapy for locally advanced adenocarcinoma of the stomach or gastroesophageal junction.
Yazar:: Guichao Li, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Evaluating the Predictive Value of the Dose-volume Parameters and Vascular Endothelial Growth Factor Expression on Rectal Toxicity in Prostate Cancer Patients
Yazar:: Marziyeh Mirzaeiyan, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)